Towards the clinical validity of tumor organoid drug screens: Establishing a framework for organoid disease models.

e15037Background: Despite advances in biomarker-directed cancer therapies to predict tumor response to treatment, precision oncology remains an imprecise science. Tumor organoid drug screens presen...